(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-20 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 651344
| Date | Daily Closing Price | Open | High | Low | Volume |
| 20 Tue Aug 2024 | 93.20 | 94.18 | 95.20 | 92.92 | 0.54 times |
| 19 Mon Aug 2024 | 95.70 | 93.35 | 95.74 | 92.77 | 0.578 times |
| 16 Fri Aug 2024 | 93.49 | 95.44 | 95.99 | 93.15 | 0.918 times |
| 15 Thu Aug 2024 | 95.52 | 95.60 | 96.21 | 94.33 | 0.824 times |
| 14 Wed Aug 2024 | 93.36 | 93.11 | 94.31 | 91.82 | 0.887 times |
| 13 Tue Aug 2024 | 92.82 | 94.43 | 95.39 | 91.55 | 1.047 times |
| 12 Mon Aug 2024 | 93.71 | 94.44 | 95.33 | 93.43 | 0.785 times |
| 09 Fri Aug 2024 | 93.90 | 91.80 | 94.70 | 90.74 | 1.091 times |
| 08 Thu Aug 2024 | 91.44 | 91.38 | 91.74 | 89.44 | 1.379 times |
| 07 Wed Aug 2024 | 90.85 | 94.52 | 94.52 | 90.40 | 1.111 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 91 as stoploss in an intra day buy trade for a target of 99.16. However, stock will show a bearish move below 91.
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 84.33 |
| Downside Target | 89.35 |
| Upside Target | 95.50 |
| Upside Target | 100.67 |
| Upside Target | 106.56 |
| Upside Target | 108.40 |
| Upside Target | 111.02 |
| Upside Target | 111.42 |
| Upside Target | 112.02 |
| Upside Target | 112.64 |
| Upside Target | 118.91 |
| Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 92.07 |
| Downside Intraday Target | 90.93 |
| Upside Intraday Target | 95.04 |
| Upside Intraday Target | 96.87 |
| Upside Intraday Target | 93.9 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 20 Tue Aug 2024 | 93.20 | 93.35 | 95.74 | 92.77 | 0.251 times |
| 16 Fri Aug 2024 | 93.49 | 94.44 | 96.21 | 91.55 | 0.608 times |
| 09 Fri Aug 2024 | 93.90 | 90.00 | 95.91 | 89.35 | 0.68 times |
| 02 Fri Aug 2024 | 96.72 | 112.44 | 112.64 | 95.50 | 2.675 times |
| 26 Fri Jul 2024 | 112.19 | 116.25 | 118.91 | 112.02 | 0.705 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 20 Tue Aug 2024 | 93.20 | 106.51 | 108.40 | 89.35 | 0.943 times |
| 31 Wed Jul 2024 | 108.30 | 107.68 | 121.90 | 106.56 | 1.132 times |
| 28 Fri Jun 2024 | 107.78 | 106.43 | 111.42 | 100.67 | 0.902 times |
| 31 Fri May 2024 | 105.56 | 91.44 | 111.02 | 90.85 | 1.009 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 93.14 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 93.14 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.